{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P00439",
      "entity_text" : "PAH",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:11540687",
      "entity_text" : "Dasatinib",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Dasatinib, a tyrosine kinase inhibitor used to treat acute and chronic leukemia, has been reported to cause PAH, and in most cases cessation of the drug resolves the PAH [XREF_BIBR].",
  "reading_complete" : "2020-07-28T11:13:29Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T11:05:49Z",
  "trigger" : "cause",
  "evidence" : [ "Dasatinib, a tyrosine kinase inhibitor used to treat acute and chronic leukemia, has been reported to cause PAH" ],
  "pmc_id" : "7123640",
  "score" : 0
}